These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11566430)

  • 1. Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.
    Bustillo JR; Lauriello J; Rowland LM; Jung RE; Petropoulos H; Hart BL; Blanchard J; Keith SJ; Brooks WM
    Psychiatry Res; 2001 Oct; 107(3):135-49. PubMed ID: 11566430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
    Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
    Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.
    Bustillo JR; Lauriello J; Rowland LM; Thomson LM; Petropoulos H; Hammond R; Hart B; Brooks WM
    Schizophr Res; 2002 Dec; 58(2-3):313-21. PubMed ID: 12409172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response.
    Ertugrul A; Volkan-Salanci B; Basar K; Karli Oguz K; Demir B; Ergun EL; Senturk S; Erbas B; Cila A; Ulug B
    Psychiatry Res; 2009 Nov; 174(2):121-9. PubMed ID: 19837567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex.
    Lahti AC; Holcomb HH; Weiler MA; Medoff DR; Frey KN; Hardin M; Tamminga CA
    Neuropsychopharmacology; 2004 Jan; 29(1):171-8. PubMed ID: 14520337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
    Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
    Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.
    Bustillo J; Wolff C; Myers-y-Gutierrez A; Dettmer TS; Cooper TB; Allan A; Lauriello J; Valenzuela CF
    Schizophr Res; 2004 Jan; 66(1):31-9. PubMed ID: 14693350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM; Lenkinski RE; Gur RE; Gur RC
    Neuropsychopharmacology; 1999 Feb; 20(2):131-40. PubMed ID: 9885793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia.
    Ende G; Braus DF; Walter S; Weber-Fahr W; Soher B; Maudsley AA; Henn FA
    Schizophr Res; 2000 Feb; 41(3):389-95. PubMed ID: 10728716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.
    Arango C; Breier A; McMahon R; Carpenter WT; Buchanan RW
    Am J Psychiatry; 2003 Aug; 160(8):1421-7. PubMed ID: 12900303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
    Toua C; Brand L; Möller M; Emsley RA; Harvey BH
    Neuroscience; 2010 Jan; 165(2):492-9. PubMed ID: 19854242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.
    Zink M; Schmitt A; May B; Müller B; Demirakca T; Braus DF; Henn FA
    Schizophr Res; 2004 Feb; 66(2-3):151-7. PubMed ID: 15061247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study.
    Brooks WM; Hodde-Vargas J; Vargas LA; Yeo RA; Ford CC; Hendren RL
    Biol Psychiatry; 1998 Feb; 43(4):263-9. PubMed ID: 9513735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia.
    McQueen G; Sendt KV; Gillespie A; Avila A; Lally J; Vallianatou K; Chang N; Ferreira D; Borgan F; Howes OD; Barker GJ; Lythgoe DJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Schizophr Bull; 2021 Apr; 47(3):662-671. PubMed ID: 33398325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels.
    Bustillo J; Barrow R; Paz R; Tang J; Seraji-Bozorgzad N; Moore GJ; Bolognani F; Lauriello J; Perrone-Bizzozero N; Galloway MP
    Neuropsychopharmacology; 2006 Apr; 31(4):751-6. PubMed ID: 16132064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
    Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.